Healthcare Chatbots Market In-Depth Analysis Globally by Top Key Players

 

Healthcare chatbots are artificial intelligence (AI)-powered programs that assist patients with queries. A new report on the global Healthcare chatbots market, published by Market Research Future (MRFR), evaluates that this market could mark an aggrandizement at 21.10% CAGR between 2018 and 2023. In terms of value, the market can be worth the USD 316.85 Mn by the end of the forecast period.

An remarkable market driving factor of the global healthcare chatbots market is growing trust towards chatbots by patients, which is evident due to increeasing number of healthcare mobile applications. Other market driving factors include emergence of telehealth, remote healthcare, and increasing number of doctors using mobile applications for treating patients. However, shortage of skilled healthcare IT professionals and the concerns of data privacy can create hurdles in the market growth.

Key Players

Major players in the global healthcare chatbots market include Ada Health GmbH (Germany), Babylon Health (UK), Buoy Health Inc. (USA), GYANT.COM, Inc. (USA), HealthTap Inc. (USA), Infermedica (Poland), PACT Care BV (The Netherlands), Sensely Inc. (USA), Woebot Labs Inc. (USA), and Your MD (UK).



Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6476

Market Segmentation

The global healthcare chatbots market segmentation covers application, component, deployment, and end-user. MRFR‘s take on the market allows an in-depth look into various facets of the market.

The application-based segmentation of this healthcare chatbots market covers medication assistance and appointment scheduling & medical guidance. Medication assistance segment holds the 85% market share and it can be worth USD 268.60 Mn by 2023. Healthcare chatbots are being increasingly used for organizing healthcare records and for tackling patient engagement. Holding the 15% share in the market, the appointment scheduling & medical guidance can be worth USD 48.25 Mn by 2023 due to the use of virtual assistants for reducing response times.

Regarding component, the healthcare chatbots market has been segmented into services and software. Holding the 82.1% of market share, the software segment can be worth USD 264.07 Mn while growing 21.40% CAGR. Powered by AI and natural language processing (NLP), software can provide relevant and unbiased data. Service segment can be worth USD 52.77 Mn by 2023, growing at 21.40% CAGR.

Based on the deployment, the healthcare chatbots market has been segmented into cloud deployment and on-premise deployment. The on-premise segment holds 64.6% of the market and it can be worth USD 203.36 Mn by 2023. The benefits of on-premise deployment include lowered operational expenditure costs and efficiency & customization for providing personalized care services. The cloud deployment segment holds the 35.4% of market share and it can be worth USD 113.48 Mn by 2023. Along with storage, cloud deployment makes the retrieval of clinical and non-clinical data records easy.

In the context of end-users, the market has been segmented into healthcare providers, insurance companies, patients, and others. Holding the lion's share of 58.4%, patients segment dominates the market due to the the need for real-time diagnosis that healthcare chatbots can offer. Healthcare chatbots can also alert patients to take medications at right time and report in case of missed dosage. The second largest market share of 28.7% is held by healthcare providers whose market worth by 2023 can be USD 92.11 Mn. During the forecast period, it can grow at 21.34% CAGR. The insurance companies segment holds 8.5% market share whereas, the Others segment holds 4.4% of the market share.

Regional Segmentation

A geographical outlining of the global healthcare chatbots market encompasses Europe, The Americas (North America& South America), Asia Pacific, and the Middle East & Africa (MEA).

By the end of forecast period, Europe is expected to continue to dominate the global market and its market worth is going to be USD 129.36 Mn. Europe holds the 40.3% share in the global market. The key factors contributing to the market growth in this region include adoption of healthcare chatbots to mitigate the burden of hospitals, investments to expedite the development of AI, high density of population, high disposable income, and increasing prevalence of chronic diseases. Many important market players are based in Europe. Due to technological advancement, economic development, and availability of advanced medical facilities, Western Europe is a bigger regional market segment compared to Eastern Europe. In this region, the greatest country-specific markets are France, Germany, Italy, Spain, and the UK.  An analysis of the remaining countries in Western Europe featured in this report estimates the huge contribution to market revenue from some other countries. Some revenue also comes from Eastern Europe.

The Americas is another significant. Many important market players are based in North America, especially in USA and technologically North America is more advanced than Europe. Due to the reasons same as Europe, North America is a bigger regional market segment, compared to South America. After USA, Canada is the most eventful country-specific market. By 2023, the total worth of of the  The Americas market can be USD 117.18 Mn.

During the forecast period, the Asia Pacific region can rise at 21.16% CAGR and by 2023, its market worth can be USD 60.48 Mn. In this region, the market is growing due to initiatives by governments of Asian countries to accelerate development of AI. Drug manufacturers are also developing their own chatbot to deal with various queries that potential customers can ask on thecompany websites of drug manufacturers. The essential country-specific markets in this region are Australia, China, India, Japan, and South Korea. An analysis of the remaining countries in the Asia Pacific region featured in this report estimates the huge contribution to market revenue from some other countries.

In the MEA region, the market  holds small share in global market due to the less emphasis on improving healthcare, limited availability of technology, a lack of awareness, and poor economies.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/healthcare-chatbots-market-6476

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market 2020: Global Industry Exhibits Huge Growth by Top Key Players

Image
  Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. The Global Proteomics Market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation proteomics workflows. ...
Read more

Pemphigus Market Astonishing Growth with Top Influencing Key players

Image
  Pemphigus is a group of IgG-mediated autoimmune diseases of the skin and oral mucosa which causes blister and erosions on the skin. In pemphigus immune system mistakenly produces antibodies that attack healthy cells in skin and mucosa. Sometimes it may also occur due to a side effect of medication such as blood pressure drugs. Blisters that occurs on the skin may be referred to as flaccid bullae because they are not firm, and break opens easily. Factors such as increasing prevalence of cancer, awareness regarding oral hygiene and unhealthy lifestyle drive the growth of global pemphigus market. Whereas rising investment in research and development activities and increasing healthcare expenditure are few more propellents of global pemphigus market. Pemphigus market size is expected to grow significantly over the forecast period. It is estimated that the pemphigus market is expected to register a CAGR of ~ 45% during the forecast period from 2018 to 2023. On the other hand, the...
Read more

Pemphigus Market Size Global Gathering and Future Outlook 2020 to 2027

Image
  Pemphigus is a group of IgG-mediated autoimmune diseases of the skin and oral mucosa which causes blister and erosions on the skin. In pemphigus immune system mistakenly produces antibodies that attack healthy cells in skin and mucosa. Sometimes it may also occur due to a side effect of medication such as blood pressure drugs. Blisters that occurs on the skin may be referred to as flaccid bullae because they are not firm, and break opens easily. Factors such as increasing prevalence of cancer, awareness regarding oral hygiene and unhealthy lifestyle drive the growth of global pemphigus market. Whereas rising investment in research and development activities and increasing healthcare expenditure are few more propellents of global pemphigus market. Pemphigus market size is expected to grow significantly over the forecast period. It is estimated that the pemphigus market is expected to register a CAGR of ~ 45% during the forecast period from 2018 to 2023. On the other hand, the...
Read more